CC
California Compounding Company, Inc.
SEC filingPharmaceuticals · Los Angeles, CA
Amount raised$4.9Msold at filing
Total offering$14.5M$9.6M still open
Investors in the raise4count reported to the SEC
FiledMay 12, 2026first sale May 1, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Tyler TarrExecutive Officer
Alex FerrieraExecutive Officer, Director
Justin LyleExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.